Stryker Corporation (SYK) : Net money flow in Stryker Corporation (SYK) was negative ($2.2 million) and the inflow of money on uptick was $14.18 million, whereas, the outflow of money on downticks amounted to $16.39 million on Wednesday. The traders used every opportunity of price strength in the stock to sell their positions, hence, the total uptick to downtick ratio was 0.87. The block trades show that the large investors, were aggressive sellers in the stock. The total value of block trades on upticks was only $1.58 million. On the other hand, the total value of block trades done on downticks was $1.23 million. The ratio of uptick to downtick block trades was 1.29. The money flow in block trades was negative ($0.35). Stryker Corporation (SYK) gained $0.83 cent during the day and reached $122.59, a gain of 0.68% over the previous day.
Also, Guggenheim Securities initiates coverage on Stryker Corporation (NYSE:SYK).The analysts at the brokerage house have a current rating of Buy on the shares. The rating by the firm was issued on June 9, 2016.
Stryker Corporation (NYSE:SYK): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $122.30 and $121.77 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $122.65. The buying momentum continued till the end and the stock did not give up its gains. It closed at $122.36, notching a gain of 0.49% for the day. The total traded volume was 1,297,449 . The stock had closed at $121.76 on the previous day.
The stock has recorded a 20-day Moving Average of 2.08% and the 50-Day Moving Average is 6.19%. In a related news,The director of Stryker Corp, Stryker Ronda E sold 12,000 shares at $122.48 on July 14, 2016. The Insider selling transaction had a total value worth of $1,469,760. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.